3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
9
Prostatic Neoplasms
9
Glioma
9
Osteosarcoma
8
Neuroblastoma
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Rhabdoid Tumor
7
Neoplasm Metastasis
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Lymphoma
6
Lung Neoplasms
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
5
Central Nervous System Neoplasms
5
Carcinoma, Hepatocellular
5
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Interventions
ruxolitinib
6
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Injections
2
Cyclophosphamide
2
Busulfan
2
Biopsy
2
veliparib
1
piperine
1
iadademstat
1
fludarabine
1
fedratinib
1
demethoxycurcumin
1
decitabine and cedazuridine drug combination
1
bomedemstat
1
Transplantation
1
Topotecan
1
Stem Cell Transplantation
1
Sirolimus
1
Resistance Training
1
Radiotherapy
1
N(4)-oleylcytosine arabinoside
1
Methotrexate
1
Melphalan
1
Liposomes
1
INCB057643
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thrombocythemia, Essential
×
X-Rays
×
90 days
×
Clear all
No trials found.